Article
Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal.
Sexual medicine reviews - 1 Oct 2020
Mostafa Taymour, Hassan Ashraf, Alghobary Moheiddin F, Abdelrahman Sherine H
Abstract excerpt
INTRODUCTION: Several treatment strategies are nowadays available for erectile dysfunction (ED) patients. Currently, oral phosphodiesterase type 5 inhibitors (PDE5Is) are the first-line therapy for ED. However, they are effective in all treated cases with variable non-responsiveness. Many factors have been listed for this behavior, but the possibility of gene polymorphisms as an underlying cause has not been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
